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The antiproliferative effects of somatostatin on he- 
patocytes stimulated by hepatocyte growth factor 
(HGF) or epidermal growth factor (EGF) were in- 
vestigated using primary cultures of adult rat bepa- 
tocytes. Somatostatin inhibits HCF-induced (at a 
dose of 10 ng/mL) or EGF-induced (at a dose of 
100 ng/mL) 3H-thymidine incorporation into be- 
patocytes in a dose-dependent manner (lo-lo to 
10B8 M) . This inhibition was confirmed by autora- 
diography. The effect of somatostatin was nontoxic 
as judged by preserved albumin synthesis, a marker 
for differentiated hepatocyte function. In the pres- 
ence or absence of somatostatin, neither HGF nor 
EGF significantly altered intracellular cyclic adeno- 
sine monophosphate (CAMP). We conclude that so- 
matostatin is a potent inhibitor of HGF- or EGF-in- 
duced deoxyribonucleic acid synthesis in adult rat 
hepatocytes. The mechanism of this inhibition ap- 
pears to be independent of CAMP. The significance 
of somatostatin in liver regeneration has yet to be 
assessed. 
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T he liver has a remarkable capacity to regenerate after hepatectomy or injury. In normal rats, resected liver 
grows rapidly, doubles in size within 48 hours, and re- 
sumes its original volume within 7 to 10 days [I]. There 
have been a variety of investigations on humoral factors 
that may trigger or promote liver growth. Insulin, gluca- 
gon, epidermal growth factor (EGF), norepinephrine, 
and vasopressin are all known hepatotrophic factors [2]. 
Recently, hepatocyte growth factor (HGF) has been dis- 
covered as a potent liver mitogen and has been postulated 
to play a major role in liver growth [3,4]. 
In contrast to uncontrolled or autonomous tumor 
growth, cellular proliferation associated with liver regen- 
eration is strictly controlled and ceases once the original 
liver mass is restored. A variety of tissue specific sub 
stances that inhibit deoxyribonucleic acid (DNA) syntha 
sis of the liver in uitro [5] or in uiuo [q have been suggest- 
ed to explain this strict regulation. However, only 
transforming growth factor ,6 [7,8] and heparin-binding 
growth factor type 1 [9] have been well characterized. 
Our knowledge of the regulating process of this phenome- 
non is still incomplete. 
Somatostatin is known to inhibit the growth of a num- 
ber of cell types such as gastrointestinal mucosa [ZO], 
exocrine pancreas [ 1 I 1, lymphocytes [ 121, and some tu- 
mors [13]. We have recently shown that somatostatin 
inhibits DNA synthesis in rat hepatocytes stimulated by 
insulin or CAMP analogue [14,15] and that the liver takes 
up intraportally injected somatostatin-14 in an eflicient 
and saturable manner [16]. These findings, taken togeth- 
er with the fact that immunoreactive somatostatin levels 
measured in the portal vein are 10 times higher than in 
systemic circulation [ 171, have led us to hypothesize that 
somatostatin may play an important role in regulating 
liver regeneration. In this study, we used primary cultures 
of adult rat hepatocytes to investigate the effects of soma- 
tostatin on DNA synthesis stimulated by HGF or EGF. 
MATERIAL AND METHODS 
Materials: Synthetic somatostatin-14 (SS-14), hu- 
man insulin, and epidermal growth factor fragment [Cys- 
(Acm20*31)]-EGF20-31 (EGF) [18] were purchased 
from Peninsula Laboratories, Inc. (Belmont, CA). Hu- 
man recombinant HGF (HGF) [4] was kindly supplied 
by Dr. Tcshikazu Nakamura (Fukuoka, Japan). Collagen- 
ase (type I) was obtained from Sigma Chemical Co. (St. 
Louis, MO). Matrigel and Dispase were obtained from 
Collaborative Research Inc. (Bedford, MA). All chemi- 
cals used for sodium dodecyl polyacrylamide gel electro- 
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Figure 1. immunoblot analysis of albumin secreted into the media 
by rat heq&cytes. The media (25 4) from hepatccyte culture 
dishes tmated with appropriate reagerh for 24 hours were sub- 
jecM to electrophoresis (SDS-PAGE) and immunobiot analysis 
using antirat albumin antltxdies (Crganon Teknlka Corp., West- 
chester, PA) [ 74,271. MM: media oniy, HGF: 10 ng/mL, EGF: 
100 ng/mL, SS-14: lOma M. The f&re is representative of three 
independent e~iments. EGF = epidermai gowth factor: HGF 
= hepakxyte gowth fector; SS-14 = synthetic somatostatin-14; 
MEM = minimum essential medium; kDa = kiiodaitons. 
phoresis and immunoblot analysis were obtained from 
BioRad (Richmond, CA). 
Hepatocyte isolation: The hepatocytes of Sprague- 
Dawley male rat (250 to 275 g) were isolated using a two- 
step collagenase perfusion technique described previously 
[24,I5,19]. Briefly, rat liver was portally perfused for 10 
minutes with Mg*+/Ca*+ free Hank’s buffer at 37’C 
followed by 8 to 10 minutes with Eagle’s minimum essen- 
tial medium (MEM) (GIBCO, Grand Island, NY) con- 
taining 0.05% collagenase (type I). The liver was excised 
and placed in a Petri dish containing fresh MEM with 
collagenase. The liver capsule was stripped, and cells were 
released by gentle manipulation. The resulting crude 
preparation was filtered through 250-pm nylon mesh, 
and the collagenase was inactivated with 0.5 mL of fetal 
calf serum. Centrifugal separation was employed to mini- 
mize contamination by nonparenchymal cells. Cell viabil- 
ity was tested by trypan blue exclusion (greater than 
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Figure 2. Cosedependent stimulation of ?-I-thymktine incorpora- 
tion by HGF and EGF. Freshly isolated hepatocytes were plated as 
described in text. After a 24-ho1x attachment period, media was 
changed, and hepatocyte growth factor (HGF) (0.5 to 10 ng/mL or 
epldermai growlh factor (EGF) (1 to 100 ng/mL) was added. h+ 
thymidine incorpomtion into deoxyribonucleic acid (DNA) was 
measured after M-hour exposure to %hymidlne (2 @X/dish). 
Points indicate ths means of 6 to 10 dishes from the different 
experiments; bars, SEM. “p <O-O5 versus control (0 ng/mL of 
HGF 01 EGF). 
90%). The hepatocytes were plated at a cell density of lo5 
per 16-mm tissue culture dish coated with 250 PL (1:3 
volume for volume) of Matrigel (laminin, heparan sul- 
fate, type IV collagen) [ZO]. The medium was supple- 
mented with insulin (100 ng/mL). To check the purity of 
the isolated hepatocytes and to exclude the possibility of 
toxicity by SS- 14, we carried out an immunoblot analysis 
[21] of the media from hepatocyte culture dishes treated 
with HGF or EGF in the presence or absence of SS-14. 
The immunoblot analysis of the media using antirat albu- 
min antibodies (Organon Teknica Corp., Westchester, 
PA) showed a single band of albumin, the molecular 
weight of which corresponded to chromatographically 
purified rat albumin (Organon Teknica Corp.) (Figure 
1). These findings confirm that cultured hepatocytes in 
the present study were pure and functional. 
Estimation of DNA synthesis: DNA synthesis was 
estimated by the rate of 3H-thymidine incorporation into 
DNA [22] and by autoradiographic measurement of the 
number of labeled nuclei. 
After a 24-hour attachment period, media was 
changed and the appropriate reagents were added. The 
cell culture was maintained up to 3 days, and the media 
were changed daily. 3H-thymidine (2 &i/dish) was add- 
ed 18 hours before harvest, which was performed using 
Dispase (a neutral protease produced by Bacillus poly- 
myxa) [23] for 2 hours at 37OC. Half of the harvested 
cells were processed for counting, and the other half were 
used to determine DNA content. The former half was 
filtered onto GF/C Whatman filters and rinsed with 1 
mL of ice-cold 15% trichloroacetic acid (TCA) twice and 
with 70% ethanol once. Filters were dried and placed in 
10 mL of scintillation cocktail (EcoLite, ICN Biochemi- 
cals, Inc., Irvine, CA) and were counted in a scintillation 
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7- TABLE I 
Effect of SS-14 on HGF- and EGF-Stlmulated 
Labeling Index 
Reagents Labeling Index (%)* 
Control 26.0 2 3.2 
HGF (10 ng/mL) 50.5 + 5.1+ 
+SS-14 (10 nM) 22.2 + 3.a* 
EGF (100 ng/mL) 49.0 +- 5.3+ 
+ss-I4 24.8 -c 4.7f 
HGF = hepatocyte growth factor: EGF = epidermal growth factor: SS-14 = 
synthetic somatostatln-14. 
0 , 
-co -10 -9 -a 
ss-14 (log M) 
*The labeling index, i.e., the percentage of nuclei labeled with sH-thymldine, 
was measured as described in “MatedaIs and Methods.” Data are the mean t 
SEM from 9 to 12 determinations from two different experiments. 
+p CO.05 versus control. 
*p ~0.05 versus HGF- or EGF-stimulated labeling index. 
F@re3.Effectofsynthetk somaMsWn_14 (SS14) on deoxyri- 
bonuckk acid (DNA) synthesis stlmuIatad by hepatocvte goti 
fa~vW~~fgowthfecta(E~).Hepartocyteswere 
treated with HGF (10 nghL) w with EGF (100 rig&L) in the 
preseWe W absenoe of s-14 (lo-10 to 10-e hq. MefJWds for 
determining ?+thy&dbre incoqoratlon ware as for Fig~e 2. 
PolntsltWoatethemeanskom8to8dlshesfromtwodMerent 
exp&men&; bars, SEM. l p <0.05 versus HGF- or EGF-stlmulat- 
ed 3Kthymidlne in-on ln absence of SS14. 
counter (Beckman LS 6,OOOLL, Beckman Instruments, 
Inc., Fullerton, CA). A modified diphenylamine reaction 
for desoxypentose was performed to measure DNA con- 
tent [24]. 3H-thymidine incorporation was expressed as 
counts per minute (cpm)/pg DNA. 
The labeling index, i.e., the percentage of total nuclei 
labeled with 3H-thymidine, was measured as follows. Af- 
ter l&hour exposure to 3H-thymidine (2 &i/dish), he- 
patocytes were washed twice with cold phosphate-buff- 
ered saline and fixed in 4% paraformaldehyde for 10 
minutes, coated with Kodak NTB-3 emulsion (Eastman 
Kodak, Rochester, NY) and exposed for 10 days before 
development in Kodak Dektol. The percentage of mor- 
phologically defined hepatocytes with labeled nuclei was 
determined by phase contrast microscopy. 
Cyclic AMP assay: Freshly isolated hepatocytes 
(1 05/mL) were incubated in glass tubes with the appro- 
priate reagents for 5 minutes. Following incubation, the 
test tubes were placed in an ice-water bath for 10 min- 
utes, vortexed gently, and centrifuged at 1,800g for 10 
minutes at 4OC. The pellet was deproteinized with 15% 
TCA, ether extracted, and lyophilized. Cyclic AMP lev- 
els were measured by a competitive protein binding assay 
using an Amersham kit (Amersham Life Science Prod- 
ucts, Arlington Heights, IL). 
Statistical analysis: All values shown represent the 
mean f standard error of the mean @EM). Wilcoxon 
signed rank test was used for comparing group means. 
The level of significance was established at p <0.05. 
RESULTS 
Effect of HCF and EGF on hepatocyte DNA syn- 
thesis: HGF and EGF stimulated 3H-thymidine incorpo- 
SS-14 (10nM) 
day 3 only 
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Figwe 4. Effect of timing of synthetic sornatostatin-14 (5514) 
exposure on deoxyrlbonuclelc ackl (DNA) synthesis. Hapakyte 
cultures were malntained for 3 days In the presence of epidennal 
growth factor (EGF) (100 ng/tH_), and Whymidlne lncorpomtion 
(cptn/ccg DNA) dving the last 18 hours was measured. The cells 
wereaxposedbSS14(10-~M)atvariousintervalsesindlceted 
on the ordinate. Values are expressed as % of control (no SS 
14). Columns lndlcata the means from 8 dlshes from two dment 
expaflments; bars, SEM. l p <0.05 varsus control. 
ration into hepatocytes in a dose-dependent manner (0.5 
to 10 ng/mL and 1 to 100 ng/mL, respectively, Figure 2). 
Of the tested doses, 10 ng/mL of HGF and 100 ng/mL of 
EGF were most effective, and these concentrations were 
used thereafter. 
Effect of SS-14 on DNA synthesis stimulated by 
HGF and EGF: Increasing concentrations of SS- 14 
(lo-lo M to lo-* M) progressively inhibited hepatocyte 
DNA synthesis stimulated by HGF and EGF (Figare 3). 
Since the optimal effect of SS- 14 was reached at lo-* M, 
this concentration was used for all remaining experi- 
ments. No significant morphological changes in hepato- 
cytes exposed to lo-* M of SS-14 were observed. Fur- 
ther, SS-14 significantly decreased the labeling index of 
the hepatocytes stimulated by HGF or EGF (Table I). 
THE AMERICAN JOURNAL OF SURGERY VOLUME 163 JANUARY 1992 171 
KOKUDO ET AL 
Thii also confirms the inhibitory effect of SS- 14 on DNA 
synthesis stimulated by HGF or by EGF. 
Effect of timing of SS-14 exposure on DNA syn- 
thesis: To determine whether a critical period exists dur- 
ing which hepatocytes are sensitive to the antiprolifera- 
tive effect of SS-14, hepatocytes stimulated with EGF 
were treated with SS-14 ( 10B8 M) at different intervals. 
In these studies (Figure 4), hepatocyte cultures were 
maintained for 3 days after attachment, and 3H-thymi- 
dine incorporation during the last 18 hours was mea- 
sured. The cells were exposed to SS-14 at various inter- 
vals as indicated on the ordinate. Exposure of cells to 
SS- 14 between days 1 and 3 produced the highest reduc- 
tion (57% f 9% of control, p <0.05) in DNA synthesis. 
Removal of SS-14 after day 1 also significantly inhibited 
DNA synthesis (65% f 6%, p <0.05). Addition of SS-14 
on day 3 did not significantly inhibit EGF-stimulated 3H- 
thymidine incorporation. 
intrinsic tyrosine kinase. Although the kinase activity is 
assumed to be important in signal generation, the mecha- 
nism coupling this early response and delayed responses 
such as DNA synthesis is unknown [28]. Human lung 
fibroblast-derived mitogen (a variant of HGF) has re- 
cently shown to induce rapid tyrosine phosphorylation in 
human mammary epithelial cells [29]. However, little is 
known about signalling mechanisms for HGF action. 
Since there were no alterations in intracellular CAMP 
levels as shown in this study, it appears that the inhibitory 
action of somatostatin on DNA synthesis stimulated by 
HGF or EGF is mediated via CAMP independent mecha- 
nism. Further study of other signal transduction systems 
may yield more information about mechanisms of hepa- 
tocyte growth regulation. 
Intracellular CAMP: The effects of HGF (10 
ng/mL) and EGF (100 ng/mL) on intracellular CAMP 
levels in the presence or absence of SS-14 were deter- 
mined in freshly isolated hepatocytes. Five minutes after 
the addition of HGF or EGF, there was no significant 
change in intracellular CAMP (2.04 f 0.52 pmol/tube 
and 2.76 f 0.48 pmol/tube, respectively; n = 5) com- 
pared with control levels (2.29 f 0.49 pmol/tube, n = 9). 
In the presence of SS- 14 ( 1 0m8 M), CAMP levels deviated 
slightly (HGF + SS-14,2.10 f 0.58 pmol/tube, EGF + 
SS-14,2.35 f 0.19 pmol/tube, n = 5), but thesechanges 
were not statistically significant. 
The significance of somatostatin for growth control in 
vivo has yet to be assessed. Somatostatin is widely distrib- 
uted in the gastrointestinal system and is produced in the 
pancreas as well as the gut [30]. Pate1 et al [17] have 
reported that immunoreactive somatostatin levels identi- 
fied in the portal vein are more than 10 times higher than 
those identified in the systemic circulation. Although the 
predominant effect of somatostatin is presumed to be 
paracrine, this peptide may directly influence the liver by 
way of the portal circulation. 
We conclude that somatostatin inhibits the early 
phase of hepatocyte proliferation stimulated by liver mi- 
togens HGF and EGF. Somatostatin may be important 
in the modulation of normal liver growth and repair, 
perhaps to prevent uncontrolled hepatocyte proliferation. 
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DISCUSSION 
William C. Meyers (Durham, NC): We’ve just com- 
pleted a similar experiment and found similar results. 
Sandostatin (Sandoz, Ltd., Basle, Switzerland) does in- 
hibit regeneration in the 70?6 hepatectomy model of Mi- 
chalopoulos (Cancer Res 1989; 49: 3314-20), and also 
BRDU (bromodeoxyuridine) incorporation. When the 
administration of Sandostatin is stopped, regeneration 
goes back to the previous curve. Have you had any experi- 
ence with an in uiuo model to confirm your results? 
David Allison (Baltimore, MD): You’ve shown that 
thymidine incorporation has been altered. As you know, 
thymidine incorporation can be influenced by the pool 
levels of thymidine in a cell. Do you have any cytophoto- 
metric evidence to show that these differences in thymi- 
dine incorporation actually relate to differences in DNA 
synthesis? 
Norihiro Kokudo (closing): We have not done any 
experiments using Sandostatin (octreotide) in uiuo. Gold- 
man (Surg Forum 1978: 29; 402-4) reported that intra- 
venous infusion of somatostatin inhibited liver regenera- 
tion after partial hepatectomy in rats. Since somatostatin 
inhibits insulin and glucagon in uiuo, which are known 
hepatotrophic factors, it is very difficult to prove whether 
there is a direct inhibitory effect of somatostatin or not. 
Dr. Allison, the histologic evidence we have relates to 
the significant changes seen in the nuclear labeling index 
(Table I). The predominance of silver grains over the 
nuclei precludes the presence of intracellular cytoplasmic 
pools of tritiated thymidine as a source of error. 
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